Department of Ophthalmology, Hospital Clínico San Carlos, Instituto de Investigación Sanitaria (IdISSC), Professor Martin Lagos s/n, 28040, Madrid, Spain.
Centro Internacional de Oftalmología Avanzada, Zurbano 71, 28010, Madrid, Spain.
Jpn J Ophthalmol. 2021 Nov;65(6):769-776. doi: 10.1007/s10384-021-00870-4. Epub 2021 Sep 7.
To assess the anterior scleral thickness (AST) and describe the presence of a visible supraciliary space (SCS) in central serous chorioretinopathy (CSC) patients by swept-source optical coherence tomography (SS-OCT).
Cross-sectional comparative study.
Three groups were studied: 1) 64 eyes of 54 patients with CSC with persistent subretinal fluid (SRF); 2) 42 fellow eyes of CSC patients without SRF; 3) 65 eyes of 65 controls matched by age, sex and axial length (AL). The AST was measured in the temporal and nasal quadrants at 0, 1, and 2 mm from the scleral spur by SS-OCT. The presence of a visible SCS was also assessed.
No differences were observed in the AST0 among the three groups (p≥ 0.665). The temporal AST1 was significantly thicker in the CSC group (530.3 ±67.1 µm) than in the controls (505.5 ±73.9; p=0.041). Mean AST2 was also thicker in the CSC group and the fellow eyes both for the temporal (519.4 ±89.1 µm and 519.8 ±98.5 µm respectively) and nasal quadrants (564.2 ±124.9 µm and 570.5 ±131.0 µm) than in the controls (450.1 ±76.8 and 473.3 ±111.6 µm) (all p≤0.001). A visible SCS was detected in the eyes of 8 CSC patients, in 4 fellow eyes and only in 1 control eye.
AST measured by SS-OCT was significantly greater in CSC eyes than in healthy eyes. Also, a visible SCS was detected in CSC eyes. Thus, thicker sclera in CSC eyes could be associated with the physiopathology of this disease.
通过扫频源光学相干断层扫描(SS-OCT)评估中心性浆液性脉络膜视网膜病变(CSC)患者的前巩膜厚度(AST)并描述可见的睫状突上腔(SCS)的存在。
横断面对比研究。
研究了三组:1)64 只眼 54 例 CSCR 患者伴有持续性视网膜下液(SRF);2)42 只眼为 CSCR 患者的对侧眼,无 SRF;3)65 只眼 65 例年龄、性别和眼轴(AL)匹配的对照组。通过 SS-OCT 在巩膜突 0、1 和 2mm 处的颞侧和鼻侧象限测量 AST。还评估了可见 SCS 的存在。
三组间 AST0 无差异(p≥0.665)。CSC 组颞侧 AST1 (530.3±67.1µm)明显厚于对照组(505.5±73.9µm;p=0.041)。CSC 组和对侧眼的颞侧和鼻侧 AST2 也较对照组厚(分别为 519.4±89.1µm 和 519.8±98.5µm,564.2±124.9µm 和 570.5±131.0µm)(所有 p≤0.001)。8 例 CSC 患者的眼中、4 例对侧眼的眼中和 1 例对照组的眼中检测到可见的 SCS。
CSC 眼中的 AST 经 SS-OCT 测量明显大于健康眼中的 AST。此外,CSC 眼中还检测到可见的 SCS。因此,CSC 眼中更厚的巩膜可能与该疾病的生理病理有关。